You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

p53 mutant

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Endometrial Cancer Trial in Worldwide (drug, radiation, other)

Recruiting
  • Endometrial Cancer
  • Toronto, Canada
  • +5 more
Jul 12, 2022

MDS, Acute Myeloid Leukemia, Myeloid Malignancy Trial in Guangzhou (Sodium stibogluconate)

Recruiting
  • Myelodysplastic Syndromes
  • +5 more
  • Sodium stibogluconate
  • Guangzhou, Guangdong, China
    First Affiliated Hospital of Jinan University
Jun 5, 2021

DLBCL Trial in Qingdao (Selinexor combined with Prednisone, Etoposide, and Lenalidomide)

Not yet recruiting
  • DLBCL
  • Selinexor combined with Prednisone, Etoposide, and Lenalidomide
  • Qingdao, Shandong, China
    the affiliated hospital of Qingdao University
Aug 18, 2022

Vulvar Cancer Trial in Vancouver (Re-excision)

Not yet recruiting
  • Vulvar Cancer
  • Re-excision
  • Vancouver, British Columbia, Canada
    BC Cancer - Vancouver Centre
Oct 8, 2022

Advanced Solid Tumor, Advanced Malignant Tumor, Metastatic Cancer Trial in United States (PC14586)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Los Angeles, California
  • +10 more
Aug 12, 2022

NSCLC Trial in Jinan (DZD9008 and Probe drugs (midazolam, digoxin, rosuvastatin))

Recruiting
  • Non-small Cell Lung Cancer
  • DZD9008 and Probe drugs (midazolam, digoxin, rosuvastatin)
  • Jinan, Shandong, China
    Shandong Cancer Hospital (Shandong Provincial Institute of Cance
Jun 22, 2023

Lung Cancer Trial in United States (Osimertinib, Platinum, Etoposide)

Recruiting
  • Lung Cancer
  • Basking Ridge, New Jersey
  • +6 more
Jul 1, 2022

Prevention of Chemo-induced Myelosuppression Trial in Worldwide (ALRN-6924, TAC (doxorubicin 50 mg/m2; cyclophosphamide 500

Recruiting
  • Prevention of Chemotherapy-induced Myelosuppression
  • ALRN-6924
  • TAC (doxorubicin 50 mg/m2; cyclophosphamide 500 mg/m2; docetaxel 75 mg/m2)
  • Tamarac, Florida
  • +14 more
Jan 31, 2023

COPD Trial in Reims (water used for oral wash, sputum, oral wash)

Completed
  • Chronic Obstructive Pulmonary Disease
  • water used for oral wash
  • +2 more
  • Reims, France
    Chu Reims
May 17, 2022

Myeloid Malignancy Trial in United States (APR-246, Venetoclax, Azacitidine)

Completed
  • Myeloid Malignancy
  • New Haven, Connecticut
  • +7 more
Jan 18, 2022

Myelodysplastic Syndrome, Acute Myeloid Leukemia, Myeloproliferative Tumor Trial in United States (APR-246, Azacitidine)

Completed
Has Results
  • Myelodysplastic Syndrome
  • +3 more
  • Tampa, Florida
  • +5 more
Jan 14, 2022

DLBCL Trial (Sintilimab, Rituximab)

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma
  • (no location specified)
Mar 6, 2022

Endometrial Cancer Trial in Vancouver (Treatment de-escalation)

Recruiting
  • Endometrial Cancer
  • Treatment de-escalation
  • Vancouver, British Columbia, Canada
    BC Cancer - Vancouver Centre
Mar 1, 2022

Endometrial Cancer Trial in Israel, United States (Selinexor, Matching Placebo for selinexor)

Recruiting
  • Endometrial Cancer
  • Miami Beach, Florida
  • +6 more
Jan 31, 2023

Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma Trial in France (Pazopanib, HDM201)

Recruiting
  • Advanced Soft-tissue Sarcoma
  • Metastatic Soft-tissue Sarcoma
  • Bordeaux, France
  • +4 more
May 5, 2022

p53 Gene in Metabolism Regulation in Li-Fraumeni Syndrome

Completed
  • Mitochondrial Disorders
  • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Nov 18, 2021

    p53 and Response to Preoperative Radiotherapy for T2 and T3

    Recruiting
    • Rectal Cancer
    • preoperative short course radiation
    • Vienna, Austria
      Medical University of Vienna, Department of Surgery
    Apr 6, 2022

    Refractory Solid Tumors Trial in Shanghai (Arsenic trioxide)

    Recruiting
    • Refractory Solid Tumors
    • Arsenic trioxide
    • Shanghai, China
      Department of Oncology, Ruijin Hospital
    May 11, 2021

    Short- and Medium-term Evaluation of Mastoid Filling Using

    Not yet recruiting
    • Cholesteatoma
    • verre bioactif 45S5 GlassBONE
    • verre bioactif S53P4 Bonalive
    • Lyon, Pierre-Bénite, France
      Hôpital Lyon Sud
    Jun 16, 2023

    Epithelial Ovarian Cancer Trial in Amsterdam (MK-1775 and carboplatin)

    Active, not recruiting
    • Epithelial Ovarian Cancer
    • MK-1775 and carboplatin
    • Amsterdam, Netherlands
      Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
    Dec 21, 2021

    Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage

    Active, not recruiting
    • Clinical Stage III Gastric Cancer AJCC v8
    • +7 more
    • Duarte, California
    • +30 more
    Jan 7, 2023

    BRAF NP_004324.2:p.V600M, BRAF V600E Mutation Present, Metastatic Thyroid Gland Carcinoma Trial in Portland (Binimetinib,

    Recruiting
    • BRAF NP_004324.2:p.V600M
    • +6 more
    • Portland, Oregon
      Providence Portland Medical Center
    Aug 17, 2022

    Solid Tumor Trial in United States (ASTX295)

    Recruiting
    • Solid Tumor
    • Duarte, California
    • +9 more
    Nov 18, 2022

    CLL/SLL Trial in Wuhan, Changsha (Orelabrutinib and BG)

    Not yet recruiting
    • CLL/SLL
    • Orelabrutinib and BG
    • Wuhan, Hubei, China
    • +1 more
    Jun 15, 2023

    Adult Solid Tumor, Bladder Carcinoma, Colon Carcinoma Trial in Duarte (Laboratory Biomarker Analysis, Modified Vaccinia Virus

    Active, not recruiting
    • Adult Solid Neoplasm
    • +16 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Mar 17, 2022